> ## Content Index > Fetch the complete content index at: https://espresso.cafecito.tech/llms.txt > Use this file to discover other available public pages before exploring further. # Seoul Court Suspends Market-Cap Delisting Rule for KOSPI, KOSDAQ - URL: https://espresso.cafecito.tech/seoul-court-suspends-market-cap-delisting/ - Published: 2026-10-05T14:32:27.000Z - Updated: 2026-10-05T14:32:27.000Z - Author: Barista @ Cafecito - Tags: Policy & Geopolitics, Politics, Business Regulation, South Korea > A Seoul court just paused the Korea Exchange's market-cap delisting mechanism — the rule that forces undersized firms off KOSPI and KOSDAQ. The 51st Civil Division found the provision unlawful: companies got no chance to object, and tightened thresholds were pulled forward six months without justification. The stakes: KOSPI's bar is 30B won (\~$21M); KOSDAQ's is 20B won (\~$14M). \~94 KOSDAQ firms could face delisting, with \~30 at immediate risk. The exchange counted 238 firms already offside by August 25, trapping 3.12M retail investors holding \~7.85T won. But injunctions aren't pardons. Jooyontech and Kmpharmaceutical are frozen pending a merit ruling; Busan Casting's request was rejected. A main judgment will decide if the cap-based exit survives. Somewhere in Yeouido, a judicial gavel has just landed on a rather inconvenient part of the Korea Exchange's rulebook — and a few dozen KOSDAQ-listed companies are breathing a cautious sigh of relief, if not ordering the champagne yet. On October 3, the Seoul Southern District Court's 51st Civil Division, under Senior Chief Judge Kwon Sung-soo, suspended the exchange's automatic-delisting mechanism for companies that fall below minimum market-capitalization thresholds. That's the rule that said, in effect: "Your stock is small now, so you're done — no hard feelings, no discussion." The court found the provision procedurally and substantively wanting. Companies got no meaningful chance to file objections or present their case before being removed, and the exchange applied its tightened thresholds six months earlier than originally scheduled, without, the court said, a convincing justification. In legal terms, the judge ruled the listing provision itself unlawful — voiding the mechanism that was forcing Jooyontech off the KOSPI and Kmpharmaceutical off the KOSDAQ. ### The arithmetic behind the drama Let's translate the stakes into figures you can actually wrap your head around. - **KOSPI threshold:** 30 billion won (\~$21 million) — for a company on the main board to keep its listing. - **KOSDAQ threshold:** 20 billion won (\~$14 million) — the junior board's bar. - **The catch:** the 30 billion won standard was initially slated for January 2027 but got yanked forward to July 2026\. Six months of "sooner than promised" does tend to annoy a court. The court noted the thresholds had been raised sharply enough that roughly 94 KOSDAQ-listed companies could fall into the delisting pool, with about 30 facing immediate risk. That's a lot of teetering corporate dominoes. And it's not just the court noticing. As of August 25, the exchange itself had counted over 238 companies failing the market-cap requirements, trapping an estimated 3.12 million retail investors holding some 7.85 trillion won in distressed firms. Those figures — flagged by the Korea Exchange before this injunction fight even got loud — give the judge's arithmetic a bit of company. ### Who's in line, and what actually stops Now, a critical distinction: an injunction is not a pardon. - Jooyontech (044380, KOSPI) and Kmpharmaceutical (225430, KOSDAQ) have had their delisting and liquidation trading **suspended** pending a merit ruling. Their September 14 delisting decisions are frozen, but the exchange can still fight the main judgment. - A pile of others — Pintel, Medicox, Eutilex, Daejin Advanced Materials (393970), Gold&S, Jeil M&S, Samyoung Electronic & Communications — have filed their own injunction requests. Each awaits an individual ruling. - Busan Casting & Engineering, notably, had its injunction request **rejected**. So the outcomes are decidedly mixed, which should tell you this isn't a blanket mass-cancellation of delistings just yet. The timeline gets even fuzzier when you recall the exchange's own September 4 concession: officials pushed the KOSDAQ delisting deadline out to July 2027, citing market-shock mitigation, even as they lifted the threshold from 4 billion won to 20 billion won and stretched the recovery window from 10 to 45 consecutive trading days. So the exchange has been negotiating with itself about timing while the court hands out injunctions one company at a time — a regulatory two-step with no obvious choreographer. ### The transmission path to your balance sheet Here's the mechanism chain worth tracking: the court's ruling → delisting decisions suspended → liquidation trading frozen → companies that would otherwise be clawed off the board keep trading → liquidity (and presumably share prices) don't get vaporized overnight. On the flip side, the regulators' "value-up" policy drive takes a blow, since the market-cap floor was a tidy blunt instrument for cleaning up undersized listings. Regulators have also flagged a new delisting trigger for penny stocks under 1,000 won and an expanded substantive-review net covering semi-annual capital-impairment assessments — so the purge has multiple doors, even if one of them just got jammed. ### What to watch A few unresolved questions hang over the exchange's head: - Will a **main judgment** side with the injunction, permanently neutering the cap-based exit standard? - Will regulators rework the system to guarantee objection-filing opportunities — and quietly reintroduce the thresholds through a different door? - Does this stall the penny-stock purge (sub-1,000 won shares) and KOSDAQ's restructuring into separate market segments — and what happens to the 238 companies already offside as of August 25? None of this is investment advice — it's just observing that in Seoul, for now, the guillotine has a temporary court-ordered maintenance inspection.